Bms (bristol Myers Squibb)

Bristol Myers Squibb (BMS) is a leading global biopharmaceutical company specializing in discovering, developing, and delivering innovative medicines for serious diseases, including cancer, cardiovascular conditions, immunology, and rare disorders. The company generates revenue primarily through the sale of prescription drugs, with blockbuster products like Opdivo and Eliquis driving significant growth. Founded in 1887, BMS has a rich history marked by strategic acquisitions, such as Celgene in 2019, which expanded its oncology and immunology portfolio. Known for its commitment to scientific innovation and patient care, BMS emphasizes advancing treatments that address unmet medical needs.

Recent Posts by Bms (bristol Myers Squibb)

1-1 of 1